Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Oropharynx”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00057850
What this trial is testing

BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Looking for participantsNCT06702033
What this trial is testing

The Minimalist Trial-2

Who this might be right for
HPV-Related Oropharynx Squamous Cell Carcinoma
Washington University School of Medicine 142
Not applicableEnded earlyNCT02177838
What this trial is testing

Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer

Who this might be right for
Stage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the LarynxStage III Squamous Cell Carcinoma of the Oropharynx+9 more
Rutgers, The State University of New Jersey 8
Early research (Phase 1)Study completedNCT01721525
What this trial is testing

Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC)

Who this might be right for
Head and Neck CancerSquamous Cell Cancer
Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT03515538
What this trial is testing

Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers

Who this might be right for
Oral Mucositis
EpicentRx, Inc. 53
Not applicableLooking for participantsNCT05539638
What this trial is testing

The Role of Circulating Tumour DNA in Head and Neck Cancer

Who this might be right for
Oropharyngeal Squamous Cell CarcinomaHuman Papillomavirus (HPV)
University of Edinburgh 250
Not applicableStudy completedNCT01487733
What this trial is testing

Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group 155
Not applicableStudy completedNCT01330147
What this trial is testing

HPV Prevalence in the Mouth and Oropharynx of the Tonsillectomy Population

Who this might be right for
Chronic Tonsillitis
University of Birmingham 937
Testing effectiveness (Phase 2)Looking for participantsNCT05491512
What this trial is testing

Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer

Who this might be right for
HPVThroat CancerOropharyngeal Carcinoma+2 more
Memorial Sloan Kettering Cancer Center 121
Not applicableStudy completedNCT00898300
What this trial is testing

Collecting and Storing Tissue Samples From Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Radiation Therapy Oncology Group 351
Not applicableStudy completedNCT02792322
What this trial is testing

Robotic Surgery in the Seated Position for Benign and Malignant Lesions of the Head and Neck

Who this might be right for
Oropharyngeal NeoplasmsHead and Neck Cancer
Mayo Clinic 32
Early research (Phase 1)Study completedNCT00021424
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck CancerMetastatic Cancer
National Institute on Deafness and Other Communication Disorders (NIDCD)
Testing effectiveness (Phase 2)Study completedNCT02508389
What this trial is testing

The Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer

Who this might be right for
Radiation Induced Oral Mucositis
Galera Therapeutics, Inc. 223
Testing effectiveness (Phase 2)Study completedNCT00721513
What this trial is testing

Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Wake Forest University Health Sciences 20
Testing effectiveness (Phase 2)Study completedNCT00939627
What this trial is testing

Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+34 more
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Study completedNCT01341535
What this trial is testing

Comparison of Adaptive Dose Painting by Numbers With Standard Radiotherapy for Head and Neck Cancer.

Who this might be right for
Primary Non-operated Squamous Cell Carcinoma of Oral CavityPrimary Non-operated Squamous Cell Carcinoma of OropharynxPrimary Non-operated Squamous Cell Carcinoma of Hypopharynx+1 more
University Hospital, Ghent 100
Not applicableActive Not RecruitingNCT04667585
What this trial is testing

Radiotherapy Dose De-escalation in HPV-Associated Cancers of the Oropharynx

Who this might be right for
Oropharynx Cancer
Duke University 120
Not applicableActive Not RecruitingNCT06592716
What this trial is testing

Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples?

Who this might be right for
Oropharynx CancerOropharynx Cancer, MetastaticOropharynx Cancer, Recurrent+2 more
Rigshospitalet, Denmark 200
Early research (Phase 1)Study completedNCT00049166
What this trial is testing

Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer

Who this might be right for
Stage II Squamous Cell Carcinoma of the Lip and Oral CavityStage II Squamous Cell Carcinoma of the OropharynxStage III Squamous Cell Carcinoma of the Lip and Oral Cavity+3 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)WithdrawnNCT02119728
What this trial is testing

Photodynamic Therapy With HPPH in Treating Patients With Squamous Cell Carcinoma of the Oral Cavity

Who this might be right for
Recurrent Squamous Cell Carcinoma of the Lip and Oral CavityRecurrent Squamous Cell Carcinoma of the OropharynxRecurrent Verrucous Carcinoma of the Oral Cavity+18 more
Roswell Park Cancer Institute
Next Page